Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

NCT01375816 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

55

Enrollment

OTHER

Sponsor class

Stopped efficacy interim analysis as per protocol

Conditions

Colorectal Cancer

Interventions

DRUG: FOLFIRI 1-Bevacizumab
DRUG: fluorouracil
DRUG: irinotecan hydrochloride
DRUG: leucovorin calcium
DRUG: liposome-encapsulated irinotecan hydrochloride PEP02
DRUG: Bevacizumab

Sponsor

GERCOR - Multidisciplinary Oncology Cooperative Group